Review articlePublished 2 Aug 2022
Prevalence, Effectiveness of Vaccination and Genomics of Omicron-A New Variant of SARS-CoV-2
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Omicron is a new variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and globally it created a challenging and hostile situation. it is highly contagious and has spread to more than 150 countries. Omicron variant has critical mutations in the spike protein than other Variants of Concern (VoC) -Alpha, Beta, Gamma and Delta and Variants of Interest (VoI) – Mu, Lambda. According to the latest WHO report, the United Kingdom has reported the highest number of SARS-CoV-2 Omicron variant cases. Unlike the previous SARS-CoV-2 variants including Delta, the present variant, Omicron does not lead to severe respiratory infection. The variant’s spike protein has a higher affinity for the human Angiotensin-Converting Enzyme 2 (ACE2) receptor. The present context explores the details about the epidemiology, risk assessment and the genetic comparison of Omicron with other SARS-CoV-2 variants along with the impact of vaccines on Omicron infection.
Subjects
Pulmonology & RespiratoryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPulmonary & Respiratory Medicine
- SubjectPulmonology & Respiratory
- BylineArticles whose byline prints “Ramadevi Bhogireddy”
- BylineArticles whose byline prints “Dinesh Annamalai”
- BylineArticles whose byline prints “Swetha Manohar”
- BylineArticles whose byline prints “Chitikela P Pullaiah”
- BylineArticles whose byline prints “Venkataraman Krishnamurthy”
- BylineArticles whose byline prints “S. Sugin Lal Jabaris”
